Inventor · disambiguated record
John Castle
Also filed as: CASTLE JOHN · CASTLE JOHN C · CASTLE JOHN CHRISTOPHER
5 granted patents·21 pending applications·62 citations·filing 2003–2022
79Inventor score
Files withROSETTA INPHARMATICS LLC4AGENUS INC2BioNTech SE2LIFE TECHNOLOGIES CORP2ARMOUR CHRISTOPHER D1
Top patents by PatentIndex Score
26 records- 0194US10738355B2Individualized vaccines for cancerSAHIN UGUR·Filed 2012·Granted Aug 11, 2020·41 cites·25 claims
- 0291US11248264B2Individualized vaccines for cancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GGMBH·Filed 2020·Granted Feb 15, 2022·5 cites·19 claims
- 0389US11222711B2Predicting immunogenicity of T cell epitopesBioNTech SE·Filed 2014·Granted Jan 11, 2022·11 cites·34 claims
- 0480US7150969B2Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)ROSETTA INPHARMATICS LLC·Filed 2005·Granted Dec 19, 2006·5 cites·9 claims
- 0573US2022282322A1Individualized vaccines for cancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GG·Filed 2022·Application pending·0 cites
- 0665US2010029511A1Cdna synthesis using non-random primersROSETTA INPHARMATICS LLC·Filed 2009·Application pending·0 cites
- 0762US2013252823A1cDNA SYNTHESIS USING NON-RANDOM PRIMERSLIFE TECHNOLOGIES CORP·Filed 2012·Application pending·0 cites
- 0862US2022093209A1Predicting immunogenicity of t cell epitopesBioNTech SE·Filed 2021·Application pending·0 cites
- 0960US2008187969A1Nucleic acid amplification using non-random primersROSETTA INPHARMATICS LLC·Filed 2006·Application pending·0 cites
- 1054US2020237885A1Vaccines for treatment and prevention of cancerAGENUS INC·Filed 2020·Application pending·0 cites
- 1153US2011294701A1Nucleic acid amplification using non-random primersCASTLE JOHN·Filed 2011·Application pending·0 cites
- 1251US2011039732A1cDNA Synthesis Using Non-Random PrimersLIFE TECHNOLOGIES CORP·Filed 2010·Application pending·0 cites
- 1350US2005003402A1Novel isoforms of centromere protein E (CENPE)Filed 2004·Application pending·0 cites
- 1450US2005089912A1Alternatively spliced isoforms of nuclear factor kappa-B, subunit 1 (NFKB1)Filed 2004·Application pending·0 cites
- 1548US2005112633A1Alternatively spliced isoforms of sodium channel, voltage gated, type VIII, alpha (SCN8A)Filed 2004·Application pending·0 cites
- 1648US2005176125A1Alternatively spliced isoform of CDC25A phosphatase and methods of useROSETTA INPHARMATICS LLC·Filed 2004·Application pending·0 cites
- 1747US2006177828A1Alternatively spliced isoform of mitotic centromere-associated kinesin (MCAK)ARMOUR CHRISTOPHER D·Filed 2004·Application pending·0 cites
- 1846US2005059088A1Alternatively spliced isoforms of receptor-interacting serine-threonine kinase 2 (RIPK2)Filed 2004·Application pending·0 cites
- 1946US2004197888A1Alternatively spliced isoforms of histone deacetylase 3 (HDAC3)Filed 2003·Application pending·0 cites
- 2045US10568948B2Vaccines for treatment and prevention of cancerAGENUS INC·Filed 2016·Granted Feb 25, 2020·0 cites·21 claims
- 2145US2004081988A1Splice variant isoforms of human calcium channel CACNA1BFiled 2003·Application pending·0 cites
- 2244US2006127913A1Alternatively spliced isoforms of human PHKA2JOHNSON JASON M·Filed 2003·Application pending·0 cites
- 2344US2004224341A1Alternatively spliced isoforms of cysteine protease cathepsin K (CTSK)Filed 2004·Application pending·0 cites
- 2439US2008102475A1Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)KAN ZHENGYAN·Filed 2007·Application pending·0 cites
- 2537US2005260650A1Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha)CASTLE JOHN C·Filed 2005·Application pending·0 cites
- 2635US2005266469A1Alternatively spliced isoforms of checkpoint kinase 1 (CHK1)RAYMOND CHRISTOPHER K·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →